Vimal Kavuru - 19 Dec 2023 Form 4 Insider Report for Acasti Pharma Inc. (GRCE)

Role
Director, 10%+ Owner
Signature
/s/ Vimal Kavuru
Issuer symbol
GRCE
Transactions as of
19 Dec 2023
Net transactions value
$0
Form type
4
Filing time
20 Dec 2023, 16:08:54 UTC
Previous filing
27 Sep 2023
Next filing
13 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACST Stock Options (Right to Buy) Award $0 +10,000 $0.000000 10,000 19 Dec 2023 Class A Common Shares 10,000 $2.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options granted on 12/19/2023 under the Acasti Pharma Stock Option Plan, which vest in equal monthly installments over a period of 12 months, provided that 3/12 of the options shall be deemed to have vested upon the date of grant.